Aliases & Classifications for Factitious Disorder

Aliases & Descriptions for Factitious Disorder:

Name: Factitious Disorder 12 14
Munchausen Syndrome 12 69
Factitious Disorders 69

Classifications:



External Ids:

Disease Ontology 12 DOID:1766
ICD10 33 F68.11
ICD9CM 35 300.16
SNOMED-CT 64 31122002 430751001
UMLS 69 C0015481

Summaries for Factitious Disorder

Disease Ontology : 12 A disease of mental health where symptoms are deliberately produced, feigned or exaggerated in order to falsely demonstrate the presence of an illness.

MalaCards based summary : Factitious Disorder, also known as munchausen syndrome, is related to munchausen by proxy and psychogenic movement, and has symptoms including nervousness An important gene associated with Factitious Disorder is INS (Insulin), and among its related pathways/superpathways are Insulin secretion and Integration of energy metabolism. The drugs Pancrelipase and Aspirin have been mentioned in the context of this disorder. Affiliated tissues include skin, eye and tongue.

Wikipedia : 71 A factitious disorder is a condition in which a person, without a malingering motive, acts as if he has... more...

Related Diseases for Factitious Disorder

Diseases related to Factitious Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 57)
id Related Disease Score Top Affiliating Genes
1 munchausen by proxy 11.3
2 psychogenic movement 10.8
3 alopecia-mental retardation syndrome 2 10.2 ABCC8 INS
4 toxoplasmosis 10.2 DCXR KCNJ11
5 diaphanospondylodysostosis 10.2 ABCC8 GCK
6 noonan syndrome 3 10.2 ABCC8 KCNJ11
7 ritscher-schinzel syndrome 2 10.2 ABCC8 KCNJ11
8 b- and t-cell mixed leukemia 10.2 DCXR KCNJ11
9 hemorrhagic fever 10.1 ABCC8 KCNJ11
10 tmem231-related joubert syndrome 10.1 INS TF
11 fanconi anemia, complementation group f 10.1 ABCC8 KCNJ11
12 dracunculiasis 10.1 GCK INS
13 autoimmune disease 1 10.1 ABCC8 INS KCNJ11
14 perry syndrome 10.1 INS KCNJ11
15 ischemic heart disease 10.1 ABCC8 GCK INS
16 deafness, autosomal recessive 66 10.1 ABCC8 INS KCNJ11
17 chondroma 10.1 ABCC8 INS KCNJ11
18 nosophobia 10.1 ABCC8 GCK KCNJ11
19 anuria 10.1 ABCC8 INS
20 antidepressant type abuse 10.1 GCK INS KCNJ11
21 mosaic trisomy 13 10.0 ABCC8 GCK INS KCNJ11
22 non-syndromic intellectual disability 10.0 ABCC8 GCK INS KCNJ11
23 maturity-onset diabetes of the young, type 13 10.0 ABCC8 GCK INS KCNJ11
24 diabetic cataract 10.0 ABCC8 GCK INS KCNJ11
25 focal segmental glomerulosclerosis 8 10.0 ABCC8 GCK INS KCNJ11
26 neurogenic arthropathy 10.0 ABCC8 GCK INS KCNJ11
27 distal muscular dystrophy 10.0 ABCC8 GCK INS KCNJ11
28 exostosis 9.9 ABCC8 GCK INS KCNJ11
29 peroneal neuropathy 9.9 ABCC8 GCK INS KCNJ11
30 body dysmorphic disorder 9.9 ABCC8 GCK INS KCNJ11
31 brain stem glioma 9.9 ABCC8 GCK INS KCNJ11
32 congenital stationary night blindness 9.9 ABCC8 GCK INS KCNJ11
33 heroin dependence 9.9 KANTR KCNJ11
34 diabetes mellitus, insulin-dependent, 20 9.9 GCK INS KCNJ11 TF
35 maturity-onset diabetes of the young 6 9.8 ABCC8 GCK INS KCNJ11
36 endophthalmitis 9.8
37 peripheral nervous system neoplasm 9.8 KANTR KCNJ11
38 alcohol dependence 9.6
39 pulmonary embolism 9.6
40 reflex sympathetic dystrophy 9.6
41 postpartum depression 9.6
42 burns 9.6
43 hypersomnia 9.6
44 crohn's disease 9.6
45 usher syndrome 9.6
46 sensorineural hearing loss 9.6
47 borderline personality disorder 9.6
48 paranoid schizophrenia 9.6
49 pancytopenia 9.6
50 bipolar i disorder 9.6

Graphical network of the top 20 diseases related to Factitious Disorder:



Diseases related to Factitious Disorder

Symptoms & Phenotypes for Factitious Disorder

UMLS symptoms related to Factitious Disorder:


nervousness

Drugs & Therapeutics for Factitious Disorder

Drugs for Factitious Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 577)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Pancrelipase Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 53608-75-6
2
Aspirin Approved, Vet_approved Phase 4,Phase 3 50-78-2 2244
3
Zinc Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 7440-66-6 32051 23994
4
Pantoprazole Approved Phase 4 102625-70-7 4679
5
Ticlopidine Approved Phase 4 55142-85-3 5472
6
Rifampin Approved Phase 4 13292-46-1 5458213 5381226
7
Vancomycin Approved Phase 4 1404-90-6 441141 14969
8
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2 50-28-2 5757 53477783
9
Progesterone Approved, Vet_approved Phase 4 57-83-0 5994
10
Etomidate Approved Phase 4 33125-97-2 36339 667484
11
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3 437-38-7 3345
12
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 1 2078-54-8 4943
13
Ketorolac Approved Phase 4,Phase 3,Phase 2,Phase 1 74103-06-3, 66635-83-4 3826
14
Warfarin Approved Phase 4,Phase 3 81-81-2 6691 54678486
15
Enfuvirtide Approved, Investigational Phase 4 159519-65-0 16130199
16
Benzocaine Approved Phase 4,Phase 3 1994-09-7, 94-09-7 2337
17
Remifentanil Approved Phase 4,Phase 3 132875-61-7 60815
18
Dinoprostone Approved Phase 4,Phase 3 363-24-6 5280360
19
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 2 76631-46-4, 113775-47-6 68602 5311068 56032
20
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
21
Dopamine Approved Phase 4,Phase 2,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
22
Levodopa Approved Phase 4 59-92-7 6047
23
Glycerol Approved, Experimental Phase 4,Phase 3 56-81-5 753
24
Loteprednol Approved Phase 4 82034-46-6, 129260-79-3 444025 9865442
25
Ezetimibe Approved Phase 4 163222-33-1 150311
26
Ethanol Approved Phase 4,Phase 2 64-17-5 702
27
Ephedrine Approved Phase 4,Phase 3,Phase 1,Phase 2 299-42-3 9294
28
Pseudoephedrine Approved Phase 4,Phase 3,Phase 1,Phase 2 90-82-4 7028
29
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 3,Phase 2 9004-61-9 53477741 24759
30
Histamine Approved, Investigational Phase 4,Phase 2 75614-87-8, 51-45-6 774
31
Timolol Approved Phase 4,Phase 3,Phase 2,Phase 1 26839-75-8 33624 5478
32
Dorzolamide Approved Phase 4,Phase 2,Phase 3 120279-96-1 3154 5284549
33
Simvastatin Approved Phase 4 79902-63-9 54454
34
Isotretinoin Approved Phase 4 4759-48-2 5538 5282379
35
Bimatoprost Approved, Investigational Phase 4,Phase 2 155206-00-1 5311027
36
Dinoprost Tromethamine Approved, Vet_approved Phase 4 38562-01-5 5282415
37
Epinastine Approved, Investigational Phase 4 80012-43-7 3241
38
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 79217-60-0, 59865-13-3 5284373 6435893
39
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 22916-47-8 4189
40
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
41
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
42
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
43
Fluorouracil Approved Phase 4 51-21-8 3385
44
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
45
Pilocarpine Approved Phase 4 54-71-7, 92-13-7 5910
46
Latanoprost Approved, Investigational Phase 4,Phase 2 130209-82-4 5282380 5311221
47
Alcaftadine Approved Phase 4 147084-10-4 19371515
48
Clonidine Approved Phase 4,Phase 1 4205-90-7 2803
49
Ampicillin Approved, Vet_approved Phase 4 69-53-4 6249
50
Sulbactam Approved Phase 4 68373-14-8

Interventional clinical trials:

(show top 50) (show all 813)
id Name Status NCT ID Phase
1 Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study Unknown status NCT01800734 Phase 4
2 Comparison of Stent and Prothesis Bypass in Superficial Femoral Artery Unknown status NCT01147419 Phase 4
3 Effect of an Artificial Pancreas in Patients Undergoing Pancreatic Resection Unknown status NCT00661648 Phase 4
4 Mixed Meal Test in Type 1 Diabetes on Insulin Pump Therapy: Optimization of Artificial Pancreas Unknown status NCT02003274 Phase 4
5 The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation Unknown status NCT01078935 Phase 4
6 Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis Unknown status NCT00155363 Phase 4
7 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4
8 Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin Unknown status NCT02443064 Phase 4
9 Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients Unknown status NCT01353846 Phase 4
10 Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma Unknown status NCT01401088 Phase 4
11 NIMIP: Non Invasive Measurement of the Intracranial Pressure Unknown status NCT01685450 Phase 4
12 Combined Use of Etomidate and Propofol in Painless Gastroscopy. Unknown status NCT01913054 Phase 4
13 Comparative Study About the Impact of Two Oil Emulsions Administered Intravenously on Severe Acute Pancreatitis Unknown status NCT01376817 Phase 4
14 Clinical Investigation of the Bi Flex M Multifocal IOL Unknown status NCT02338882 Phase 4
15 A Intra-patient Comparison of Closed Loop and Plate Haptic Toric Intraocular Lenses Unknown status NCT02264457 Phase 4
16 Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity Unknown status NCT00634972 Phase 4
17 Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients Unknown status NCT01610141 Phase 4
18 Ventricular Pacing Site Selection (V-PASS) Unknown status NCT00292383 Phase 4
19 The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer Unknown status NCT01346371 Phase 4
20 Closed-Loop Target Controlled Infusion in Laparoscopic Cholecystectomy Unknown status NCT02114437 Phase 4
21 Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes Unknown status NCT02232971 Phase 4
22 The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain Unknown status NCT01417923 Phase 4
23 Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU) Unknown status NCT01059929 Phase 4
24 Mode Evaluation in Sick Sinus Syndrome Trial (MODEST) Unknown status NCT00161551 Phase 4
25 Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia Unknown status NCT00111371 Phase 4
26 The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease Completed NCT02120079 Phase 4
27 Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons Completed NCT00481351 Phase 4
28 Comparison of Autologous Serum Versus Preservative Free Artificial Tear Completed NCT02752763 Phase 4
29 Effect of an Artificial Pancreas in Patients Undergoing Hepatic Resection Completed NCT00659698 Phase 4
30 Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) Completed NCT02059655 Phase 4
31 CHARITE™ vs. ALIF 5-Year Follow-up Completed NCT00215332 Phase 4
32 Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms Completed NCT00938704 Phase 4
33 Effect of Preoperative Supplementation in Insulin Resistance Completed NCT00657124 Phase 4
34 Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients Completed NCT01682460 Phase 4
35 Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis Completed NCT01569191 Phase 4
36 Veterans Individual Placement and Support Towards Advancing Recovery Completed NCT01817712 Phase 4
37 A Study of the Effect of Zinc-Hyaluronate on Ocular Surface Sensations in Patients With Dry Eye Completed NCT02951910 Phase 4
38 A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN) Completed NCT02014922 Phase 4
39 A Study to Assess the Long-term Performance of SmartSet® HV and SmartSet® GHV Bone Cements in Primary Total Hip Replacement Completed NCT00872066 Phase 4
40 Efficacy and Acceptability of Two Lubricant Eye Drops Completed NCT00756678 Phase 4
41 Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms Completed NCT00405457 Phase 4
42 MAKE IT CLEAN, Impact of Pocket Revision on the Rate of Infection and Other Complications in Patients Requiring Pocket Manipulation for Generator Replacement and/or Lead Replacement or Revision: A Prospective Randomized Study Completed NCT00599261 Phase 4
43 Uremic Pruritus, Cytokines and Polymethylmethacrylate Artificial Kidney Completed NCT00442819 Phase 4
44 Steroids After Laser Trabeculoplasty for Glaucoma Completed NCT00981435 Phase 4
45 CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial Completed NCT00847912 Phase 4
46 A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment Completed NCT00438048 Phase 4
47 Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality Completed NCT00622037 Phase 4
48 Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK). Completed NCT00620893 Phase 4
49 A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens Completed NCT01061268 Phase 4
50 24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients Completed NCT00330577 Phase 4

Search NIH Clinical Center for Factitious Disorder

Genetic Tests for Factitious Disorder

Anatomical Context for Factitious Disorder

MalaCards organs/tissues related to Factitious Disorder:

39
Skin, Eye, Tongue

Publications for Factitious Disorder

Articles related to Factitious Disorder:

(show top 50) (show all 129)
id Title Authors Year
1
The Interplay of Factitious Disorder and Palliative Care Encounters: A Case Series. ( 26840863 )
2016
2
Chronic undiagnosed orbital inflammation due to factitious disorder: a 'think different' paradigm. ( 27557733 )
2016
3
Factitious disorder: a systematic review of 455 cases in the professional literature. ( 27302720 )
2016
4
Identifying and Managing Malingering and Factitious Disorder in the Military. ( 27752984 )
2016
5
Malingering and Factitious Disorder (MA1nchausen-syndrome) can be Mitochondrial. ( 27570349 )
2016
6
Migration of a foreign object to the parapharyngeal space: an unusual factitious disorder. ( 27381878 )
2016
7
Factitious Disorder Presenting with Attempted Simulation of Fournier's Gangrene. ( 27761196 )
2016
8
Factitious Disorder in a Patient Claiming to be a Sexually Sadistic Serial Killer. ( 27990636 )
2016
9
Between the sanitary complacency and the factitious disorder by proxy. ( 27254405 )
2016
10
Sclerosing Lipogranuloma with Multiple Skin Lesions and Pulmonary Involvement, Secondary to a Factitious Disorder. ( 26315839 )
2015
11
Paternalism and factitious disorder: medical treatment in illness deception. ( 26063587 )
2015
12
Fatal non-thrombotic pulmonary embolization in a patient with undiagnosed factitious disorder. ( 26164684 )
2015
13
Factitious disorder-by-proxy simulating fetal growth restriction. ( 25730239 )
2015
14
Factitious disorder (Munchausen's syndrome) in oncology: case report and literature review. ( 26179957 )
2015
15
Recalcitrant Supraventricular Tachycardia: Occult Albuterol Toxicity Due to a Factitious Disorder. ( 26162766 )
2015
16
Factitious Disorder in Crohn's Disease: Recurrent Pancytopenia Caused by Surreptitious Ingestion of 6-Mercaptopurine. ( 26078732 )
2015
17
Factitious Disorder Manifesting as Hematemesis and Hematochezia. ( 26137349 )
2015
18
Sensorineural hearing loss associated with a factitious disorder. ( 26670765 )
2015
19
When the lie is the truth: grounded theory analysis of an online support group for factitious disorder. ( 24745468 )
2014
20
Letter regarding: When the lie is the truth: Grounded theory analysis of an online support group for factitious disorder. ( 25169893 )
2014
21
Factitious disorder-experience at a neuropsychiatric center in southern India. ( 24701013 )
2014
22
Factitious disorder in adolescence. ( 26078677 )
2014
23
Wires in the body: a case of factitious disorder. ( 24049235 )
2013
24
A pediatric case of factitious disorder with unexplained bleeding symptoms. ( 24199786 )
2013
25
A relationship between factitious disorder and borderline personality disorder. ( 24563814 )
2013
26
Munchausen syndrome and factitious disorder: the role of the laboratory in its detection and diagnosis. ( 23592802 )
2013
27
Recovery from chronic factitious disorder (Munchausen's syndrome): a personal account. ( 24343927 )
2013
28
Factitious disorder as a cause of gastrointestinal bleeding: use of a gastroenterologist's "Secondary Survey". ( 23459058 )
2013
29
Factitious disorder in a psychogeriatric inpatient. ( 22133980 )
2012
30
Estimated cost of a factitious disorder with 6-year follow-up. ( 22771172 )
2012
31
Factitious disorder comorbid with bipolar I disorder. A case report. ( 22285502 )
2012
32
Foreign body granulomatosis in a patient with a factitious disorder. ( 23169092 )
2011
33
Laboratory diagnosis of factitious disorder: a systematic review of tools useful in the diagnosis of Munchausen's syndrome. ( 21963927 )
2011
34
Recurrent deep ulcers resembling rare cancers as a form of factitious disorder. ( 21336468 )
2011
35
Factitious disorder as repeated diabetic ketoacidosis: a case report. ( 21468297 )
2011
36
Factitious disorder as a differential diagnosis for recurrent skin graft failure. ( 21185246 )
2011
37
Pediatric condition falsification (Munchausen syndrome by Proxy) as a continuum of maternal factitious disorder (Munchausen syndrome). ( 20149125 )
2010
38
Levodopa addiction and factitious disorder in a patient with idiopathic Parkinson's disease. ( 20686151 )
2010
39
The origins of factitious disorder. ( 20549878 )
2010
40
Factitious disorder presenting as type 1 diabetes mellitus. ( 21686797 )
2009
41
Factitious disorder (Munchausen's syndrome). ( 21152477 )
2009
42
Self-inflicted non-healing genital ulcer: a rare form of factitious disorder. ( 19588064 )
2009
43
The A, B, C's of factitious disorder: a response to Turner. ( 19295948 )
2009
44
Challenges in the treatment of factitious disorder: a case study. ( 19216989 )
2009
45
Factitious disorder in children and adolescents: a retrospective study. ( 18794507 )
2008
46
Looking toward DSM-V: should factitious disorder become a subtype of somatoform disorder? ( 18621932 )
2008
47
Prevalence of factitious disorder with psychological symptoms in hospitalized patients. ( 18568455 )
2008
48
Shifting opacities on plain abdominal radiographs: a rare case of factitious disorder. ( 18495365 )
2008
49
Factitious Usher syndrome: a new type of factitious disorder. ( 18679542 )
2008
50
Factitious disorder by proxy: pediatric condition falsification. ( 18661364 )
2008

Variations for Factitious Disorder

Expression for Factitious Disorder

Search GEO for disease gene expression data for Factitious Disorder.

Pathways for Factitious Disorder

GO Terms for Factitious Disorder

Cellular components related to Factitious Disorder according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 ATP-sensitive potassium channel complex GO:0008282 8.62 ABCC8 KCNJ11

Biological processes related to Factitious Disorder according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.65 ABCC8 KCNJ11 OGG1
2 carbohydrate metabolic process GO:0005975 9.63 DCXR GCK INS
3 glucose transport GO:0015758 9.43 GCK INS
4 negative regulation of insulin secretion GO:0046676 9.4 ABCC8 KCNJ11
5 cellular glucose homeostasis GO:0001678 9.37 ABCC8 GCK
6 positive regulation of glycogen biosynthetic process GO:0045725 9.32 GCK INS
7 negative regulation of gluconeogenesis GO:0045721 9.26 GCK INS
8 NADP metabolic process GO:0006739 9.16 DCXR GCK
9 regulation of insulin secretion GO:0050796 9.13 ABCC8 GCK KCNJ11
10 glucose metabolic process GO:0006006 8.92 DCXR GCK INS KCNJ11

Molecular functions related to Factitious Disorder according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 catalytic activity GO:0003824 9.13 GCK HSD17B6 OGG1
2 ATP-activated inward rectifier potassium channel activity GO:0015272 8.62 ABCC8 KCNJ11

Sources for Factitious Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....